
Keywords: AP; activator protein-1; APC; adenomatous polyposis coli; ATM; ataxia-telangiectasia; BDNF-AS; brain-derived neurotrophic factor antisense; BIN1; bridging integrator 1; BMP6; bone morphogenetic protein 6; BRCA; breast cancer associated gene; CpG; cytosine